Abstract
Monoclonal IgM anti-erythrocyte autoantibody produced by a NZB-derived hybridoma has been found to react with trimethylammonium-containing compounds. Such compounds are able to prevent the lysis of bromelain-treated mouse erythrocytes (BrMRBC) by those autoantibodies. Using a column of insolubilized betaine hydrazide (BH) the monoclonal anti-erythrocyte antibody has been specifically retained. Elution of this antibody was accomplished by 0.15 M choline (Ch).
Original language | English |
---|---|
Pages (from-to) | 315-319 |
Number of pages | 5 |
Journal | Immunology Letters |
Volume | 3 |
Issue number | 5 |
DOIs | |
State | Published - Nov 1981 |